Table 4.
Upstream Regulator | Molecule Type | Predicted Activation State | Activation z-Score | p-Value |
---|---|---|---|---|
NFE2L2 | transcription regulator | Activated | 3.110 | 5.8E-18 |
TRAP1 | enzyme | Activated | 2.975 | 5.66E-08 |
HNF1A | transcription regulator | Activated | 2.795 | 8.18E-08 |
NR1I2 | ligand-dependent nuclear receptor | Activated | 2.470 | 1.19E-29 |
IL10RA | transmembrane receptor | Activated | 2.350 | 0.0000 |
RICTOR | other | Activated | 2.333 | 0.0012 |
CD3 | complex | Activated | 2.213 | 0.0301 |
TNF | cytokine | Activated | 2.212 | 0.0188 |
IGF-1 | growth factor | Activated | 2.200 | 0.0313 |
VCAN | other | Activated | 2 | 0.0311 |
PRKAA1 | kinase | Inactivated | −2.121 | 0.0000 |
IL4 | cytokine | Inactivated | −2.136 | 0.0169 |
WT1 | transcription regulator | Inactivated | −2.200 | 0.0377 |
PRKAA2 | kinase | Inactivated | −2.333 | 0.0000 |
Abbreviations: NFE2L2, nuclear factor, erythroid 2 like 2; TRAP1, TNF receptor associated protein 1; HNF1A, hepatocyte nuclear factor 1 homeobox A; NR1I2, nuclear receptor subfamily 1 group I member 2; IL10RA, interleukin 10 receptor subunit alpha; RICTOR, rapamycin-insensitive companion of mTOR; TNF, tumor necrosis factor; IGF-1, insulin like growth factor 1; VCAN, versican; PRKAA1, protein kinase AMP-activated catalytic subunit alpha 1; IL4, interleukin 4; WT1, Wilms tumor 1; PRKAA2, protein kinase AMP-activated catalytic subunit alpha 2.